The weight-loss drug is approved to treat obstructive sleep apnea, but some types of patients seem to benefit the most.
A single night of sleep testing may not be enough to diagnose sleep apnea, with new Flinders University research revealing ...
Integration supports remote patient monitoring and value-based care ProSomnus RPMO2 OSA Device System RPMO2 OSA Device System The only medical device integrating OAT, oximetry, a smartphone app, and a ...
Despite the use of nocturnal noninvasive ventilation (NIV), patients report having poor quality of sleep, according to a recent study. Polysomnography (PSG) guidance should be used with nocturnal ...
The American Academy of Sleep Medicine has developed and validated a patient-reported outcome tool for use in a clinical setting to monitor treatment response and longitudinal symptom progression in ...
Six weeks of sleep restriction increased weight, waist circumference, leptin levels, and time spent inactive in adults with cardiometabolic risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results